Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22026 | 24868321 | World J Hepatol | Gender and racial differences in nonalcoholic fatty liver disease. | 2014 | Details |
| A22030 | 24866317 | Rev Med Inst Mex Seguro Soc | [Nonalcoholic fatty liver disease in children]. | 2014 | Details |
| A22031 | 24865256 | Dig Dis Sci | Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. | 2014 | Details |
| A22036 | 24861026 | J Mol Med (Berl) | NLRP3 inflammasome activation is required for fibrosis development in NAFLD. | 2014 | Details |
| A22038 | 24858832 | PLoS One | β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. | 2014 | Details |
| A22039 | 24857839 | Arch Biochem Biophys | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. | 2014 | Details |
| A22045 | 24853141 | PLoS One | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. | 2014 | Details |
| A22048 | 24851523 | Trop Gastroenterol | Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. | 2014 | Details |
| A22053 | 24849310 | Hepatology | Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. | 2014 | Details |
| A22061 | 24845607 | J Hepatol | Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. | 2014 | Details |
| A22069 | 24842304 | J Hepatol | Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. | 2014 | Details |
| A22071 | 24841950 | Obes Surg | The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. | 2014 | Details |
| A22074 | 24837835 | Int J Mol Sci | Role of mitochondria in nonalcoholic fatty liver disease. | 2014 | Details |
| A22075 | 24837195 | Clin Exp Pharmacol Physiol | Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD. | 2014 | Details |
| A22076 | 24836834 | Transplant Proc | Nonalcoholic Fatty liver disease in renal transplant recipients proven by transient elastography. | 2014 | Details |
| A22083 | 24830559 | Int J Mol Sci | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22089 | 24829591 | Hepat Mon | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". | 2014 | Details |
| A22093 | 24827629 | Gut Liver | Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. | 2014 | Details |
| A22104 | 24818764 | Gastroenterology | No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. | 2014 | Details |
| A22117 | 24803983 | Oxid Med Cell Longev | BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress. | 2014 | Details |
| A22119 | 24802098 | Mamm Genome | Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. | 2014 | Details |
| A22122 | 24799988 | World J Hepatol | Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A22126 | 24798049 | Liver Int | The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22127 | 24797980 | Adv Med Sci | Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. | 2014 | Details |
| A22132 | 24796231 | Hepatol Res | Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). | 2014 | Details |
| A22135 | 24795720 | Front Immunol | Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. | 2014 | Details |
| A22138 | 24795036 | Dig Dis Sci | Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. | 2014 | Details |
| A22144 | 24791845 | Med Ultrason | Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview. | 2014 | Details |
| A22145 | 24791843 | Med Ultrason | Comparison between the M and XL probes for liver fibrosis assessment by transient elastography. | 2014 | Details |
| A22149 | 24786317 | Exp Cell Res | Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. | 2014 | Details |
| A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A22155 | 24783906 | Med Arch | Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. | 2014 | Details |
| A22157 | 24782622 | World J Gastroenterol | Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. | 2014 | Details |
| A22158 | 24782263 | Semin Liver Dis | Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. | 2014 | Details |
| A22160 | 24781986 | PLoS One | Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice. | 2014 | Details |
| A22162 | 24777953 | Hepatology | Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22173 | 24768810 | Clin Gastroenterol Hepatol | Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. | 2014 | Details |
| A22181 | 24764670 | World J Gastroenterol | Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria. | 2014 | Details |
| A22183 | 24763757 | PLoS One | Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22184 | 24761121 | Pharmacognosy Res | Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in Non Alcoholic Steatohepatitis. | 2014 | Details |
| A22187 | 24759667 | Gastroenterol Rep (Oxf) | Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. | 2013 | Details |
| A22188 | 24759663 | Gastroenterol Rep (Oxf) | Update of liver fibrosis and steatosis with transient elastography (Fibroscan). | 2013 | Details |
| A22190 | 24758559 | Biochem J | Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice. | 2014 | Details |
| A22199 | 24753132 | Hepatology | Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. | 2014 | Details |
| A22202 | 24750664 | Liver Int | The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. | 2014 | Details |
| A22204 | 24750217 | J Gastroenterol Hepatol | Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. | 2014 | Details |
| A22210 | 24747563 | Biochem Biophys Res Commun | Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. | 2014 | Details |
| A22213 | 24746708 | Gastroenterol Hepatol | [Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease]. | 2014 | Details |
| A22217 | 24743702 | PLoS One | Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A22218 | 24743504 | Eur J Gastroenterol Hepatol | Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. | 2014 | Details |
| A22227 | 24739055 | Clin Exp Pharmacol Physiol | Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. | 2014 | Details |
| A22231 | 24737902 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2014 | Details |
| A22239 | 24731656 | Lancet Diabetes Endocrinol | Effects of iron overload on chronic metabolic diseases. | 2013 | Details |
| A22240 | 24730643 | J Gastroenterol Hepatol | Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. | 2014 | Details |
| A22244 | 24726273 | Clin Res Hepatol Gastroenterol | Pediatric non-alcoholic fatty liver disease: recent advances. | 2014 | Details |
| A22254 | 24716593 | BMC Gastroenterol | Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. | 2014 | Details |
| A22271 | 24702768 | FEBS J | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. | 2014 | Details |
| A22291 | 24689101 | J Gastrointestin Liver Dis | Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases. | 2014 | Details |
| A22298 | 24684403 | Liver Int | Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. | 2014 | Details |
| A22305 | 26202505 | Hepatol Int | Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : HCC risk assessment by VTTQ. | 2014 | Details |
| A22306 | 24677740 | Pediatr Obes | Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. | 2014 | Details |
| A22313 | 24671009 | Curr Opin Gastroenterol | Current status of fibrosis markers. | 2014 | Details |
| A22314 | 24670599 | Hum Mol Genet | PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. | 2014 | Details |
| A22317 | 24668763 | Hepatology | Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. | 2014 | Details |
| A22323 | 24661406 | Hepatol Res | Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges. | 2014 | Details |
| A22328 | 24657400 | J Hepatol | Procoagulant imbalance in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22330 | 24656139 | Nutr Metab Cardiovasc Dis | Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. | 2014 | Details |
| A22336 | 24652022 | Wien Klin Wochenschr | Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease. | 2014 | Details |
| A22338 | 24651825 | J Antimicrob Chemother | Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22339 | 24651520 | PLoS One | Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat). | 2014 | Details |
| A22342 | 24650559 | Am J Pathol | Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle. | 2014 | Details |
| A22346 | 24649857 | Liver Int | Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD. | 2014 | Details |
| A22350 | 24646400 | Scand J Gastroenterol | Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? | 2014 | Details |
| A22362 | 24637477 | PLoS One | Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. | 2014 | Details |
| A22374 | 24632764 | Minerva Gastroenterol Dietol | Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease. | 2014 | Details |
| A22376 | 24631029 | Dig Liver Dis | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. | 2014 | Details |
| A22382 | 24628836 | Liver Int | n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. | 2014 | Details |
| A22383 | 24628717 | Hepatol Res | Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution. | 2014 | Details |
| A22390 | 24626178 | Cell Cycle | Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. | 2014 | Details |
| A22395 | 24621583 | J Hum Genet | Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease. | 2014 | Details |
| A22396 | 24621397 | Liver Int | Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? | 2014 | Details |
| A22400 | 24616207 | Obesity (Silver Spring) | Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children. | 2014 | Details |
| A22405 | 24608579 | Minerva Pediatr | Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children. | 2014 | Details |
| A22406 | 24607626 | J Hepatol | Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. | 2014 | Details |
| A22408 | 24607243 | J Pediatr | Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children. | 2014 | Details |
| A22414 | 24602757 | J Diabetes Complications | Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22422 | 24588719 | J Med Food | A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. | 2014 | Details |
| A22429 | 24587650 | World J Gastroenterol | Clinical approaches to non-alcoholic fatty liver disease. | 2014 | Details |
| A22433 | 24581591 | Clin Res Hepatol Gastroenterol | Non-cirrhotic portal hypertension--concept, diagnosis and clinical management. | 2014 | Details |
| A22435 | 24579874 | Clin Transplant | Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. | 2014 | Details |
| A22439 | 24577062 | J Appl Physiol (1985) | Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. | 2014 | Details |
| A22440 | 24576046 | Radiology | Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. | 2014 | Details |
| A22442 | 24575585 | Osaka City Med J | Histologically proven hepatocellular carcinoma associated with burned-out nonalcoholic steatohepatitis. | 2013 | Details |
| A22443 | 24574727 | World J Gastroenterol | Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis. | 2014 | Details |
| A22444 | 24574716 | World J Gastroenterol | Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2014 | Details |
| A22452 | 24559185 | BMC Gastroenterol | The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22455 | 24556343 | Contemp Clin Trials | Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]. | 2014 | Details |
| A22460 | 24552673 | J Pediatr Gastroenterol Nutr | Shear wave elastography in the evaluation of liver fibrosis in children. | 2014 | Details |
| A22478 | 24528633 | J Dig Dis | The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis. | 2014 | Details |